1
|
Ohji G, Ohnuma K, Ebisawa KF, Kusuki M, Ikegaki S, Ozaki H, Ariizumi R, Nakajima M, Taketani M. Comparison of Automated Point-of-Care Gram Stainer (PoCGS ®) and Manual Staining. Diagnostics (Basel) 2025; 15:1137. [PMID: 40361956 PMCID: PMC12071327 DOI: 10.3390/diagnostics15091137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Revised: 04/16/2025] [Accepted: 04/24/2025] [Indexed: 05/15/2025] Open
Abstract
Background/Objectives: Gram staining is an essential diagnostic technique used for the rapid identification of bacterial and fungal infections, playing a pivotal role in clinical decision-making, especially in point-of-care (POC) settings. Manual staining, while effective, is labor-intensive and prone to variability, relying heavily on the skill of laboratory personnel. Current automated Gram-staining systems are primarily designed for high-throughput laboratory environments, limiting their feasibility in decentralized healthcare settings such as emergency departments and rural clinics. This study aims to introduce and evaluate the Point-of-Care Gram Stainer (PoCGS®), a compact, automated device engineered for single-slide processing, addressing challenges related to portability, standardization, and efficiency in POC applications. Methods: The PoCGS® device was developed to emulate expert manual staining techniques through features such as methanol fixation and programmable reagent application. A comparative evaluation was performed using 40 urine samples, which included both clinical and artificial specimens. These samples were processed using PoCGS®, manual staining by skilled experts, and manual staining by unskilled personnel. The outcomes were assessed based on microbial identification concordance, the staining uniformity, presence of artifacts, and agreement with the culture results. Statistical analyses, including agreement rates and quality scoring, were conducted to compare the performance of PoCGS® against manual staining methods. Results: PoCGS® achieved a 100% concordance rate with expert manual staining in terms of microbial identification, confirming its diagnostic accuracy. However, staining quality parameters such as the uniformity and presence of artifacts showed statistically significant differences when compared to skilled and unskilled personnel. Despite these limitations, PoCGS® demonstrated a comparable performance regarding artifact reduction and agreement with the culture results, indicating its potential utility in POC environments. Challenges such as fixed processing times and limited adaptability to varying specimen characteristics were identified as areas for further improvement. Conclusions: The study findings suggest that PoCGS® is a reliable and valuable tool for microbial identification in POC settings, with a performance comparable to skilled manual staining. Its compact design, automation, and ease of use make it particularly beneficial for resource-limited environments. Although improvements in staining uniformity and background clarity are required, PoCGS® has the potential to standardize Gram staining protocols and improve diagnostic turnaround times. Future developments will focus on optimizing staining parameters and expanding its application to other clinical sample types, ensuring robustness and broader usability in diverse healthcare settings.
Collapse
Affiliation(s)
- Goh Ohji
- Division of Infectious Disease Therapeutics, Department of Infectious Disease, Kobe University Graduate School of Medicine, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.F.E.); (S.I.)
- Department of Clinical Laboratory, Kobe University Hospital, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.O.); (M.K.)
| | - Kenichiro Ohnuma
- Department of Clinical Laboratory, Kobe University Hospital, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.O.); (M.K.)
| | - Kei Furui Ebisawa
- Division of Infectious Disease Therapeutics, Department of Infectious Disease, Kobe University Graduate School of Medicine, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.F.E.); (S.I.)
| | - Mari Kusuki
- Department of Clinical Laboratory, Kobe University Hospital, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.O.); (M.K.)
| | - Shunkichi Ikegaki
- Division of Infectious Disease Therapeutics, Department of Infectious Disease, Kobe University Graduate School of Medicine, 7-5-2, Kusunokicho, Chuoku, Kobe 6500017, Japan; (K.F.E.); (S.I.)
| | - Hiroaki Ozaki
- CarbGeM Inc., 5-13, 1chome, Jinnan, Shibuyaku 1500041, Japan; (H.O.); (M.N.); (M.T.)
| | - Reiichi Ariizumi
- CarbGeM Inc., 5-13, 1chome, Jinnan, Shibuyaku 1500041, Japan; (H.O.); (M.N.); (M.T.)
| | - Masakazu Nakajima
- CarbGeM Inc., 5-13, 1chome, Jinnan, Shibuyaku 1500041, Japan; (H.O.); (M.N.); (M.T.)
| | - Makoto Taketani
- CarbGeM Inc., 5-13, 1chome, Jinnan, Shibuyaku 1500041, Japan; (H.O.); (M.N.); (M.T.)
| |
Collapse
|